J. Kaiser

Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93

D. Reinhardt, T. Klingebiel, U. Creutzig, 2004, Leukemia.

Antithrombotic Therapy in Patients With Thrombocytopenic Cancer

T. Trujillo, T. Kiser, J. Kaiser, 2014, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia.

B. Stevens, Amanda C. Winters, E. Purev, 2019, Blood advances.

Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplant and Hematologic Malignancy Population.

S. Mueller, D. Fish, J. Kaiser, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphoma

B. Hill, J. Kaiser, Anson Snow, 2022, Leukemia & lymphoma.

Antifungal usage in children undergoing intensive treatment for acute myeloid leukemia: analysis of the multicenter clinical trial AML-BFM 93

T. Klingebiel, A. Groll, D. Schwabe, 2007, European Journal of Clinical Microbiology & Infectious Diseases.

Letermovir prophylaxis through day 100 post transplant is safe and effective compared with alternative CMV prophylaxis strategies following adult cord blood and haploidentical cord blood transplantation

E. Purev, A. Weinberg, J. Kaiser, 2019, Bone Marrow Transplantation.